Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: White House Withdraws FDA Nomination For Dr. Heidi Overton’s
Pharmaceutical Executive Daily: White House Withdraws FDA Nomination For Dr. Heidi Overton’s

White House withdraws Dr. Heidi Overton’s FDA commissioner nomination amid Senate GOP pushback, Pfizer and Verismo advance in vivo CAR-T manufacturin…

an hour ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Cosentyx and Wilserdly
Pharmaceutical Executive Daily: FDA Approves Cosentyx and Wilserdly

Gilead signs royalty-free licensing deals to broaden Ebola antiviral access, FDA approves Cosentyx for polymyalgia rheumatica and Wilserdly for ESR1-…

1 day ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Three New Therapies
Pharmaceutical Executive Daily: FDA Approves Three New Therapies

FDA approves three new therapies, a wave of dealmaking led by Johnson & Johnson, Eli Lilly, AmyriAD Therapeutics, and Sanofi, and Ossium Health’s Kev…

2 days, 1 hour ago

Short Long
View Episode
The Ron Lanton Report: Ossium Health's Bone Marrow Bank
The Ron Lanton Report: Ossium Health's Bone Marrow Bank

Ossium Health’s Kevin Caldwell joins The Ron Lanton Report to explain how banked, deceased-donor marrow is replacing a months-long search for a livin…

2 days, 10 hours ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Shelves CNPV Program
Pharmaceutical Executive Daily: FDA Shelves CNPV Program

FDA reportedly shelves its Commissioner’s National Priority Voucher program, Eli Lilly breaks ground on a $3.5 billion Pennsylvania manufacturing sit…

5 days, 3 hours ago

Short Long
View Episode
Pharmaceutical Executive Daily: Moderna Outlines Growth Plan at 2026 Analyst Day
Pharmaceutical Executive Daily: Moderna Outlines Growth Plan at 2026 Analyst Day

Moderna lays out an oncology-driven growth plan at its 2026 Analyst Day, Pfizer and Blackstone sign a co-funding deal worth up to $1.5 billion for be…

6 days, 1 hour ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Pimjetmi
Pharmaceutical Executive Daily: FDA Approves Pimjetmi

FDA approves Merck KGaA’s Pimjetmi for tenosynovial giant cell tumor, Parexel’s Stacy Hurt on when patient input should enter the clinical research p…

1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Requires Safety Label Update on GLP-1 Receptor Agonist
Pharmaceutical Executive Daily: FDA Requires Safety Label Update on GLP-1 Receptor Agonist

FDA approves Bayer’s asundexian as the first Factor XIa inhibitor for secondary stroke prevention, the FDA requires a new safety label warning across…

1 week, 1 day ago

Short Long
View Episode
Pharmaceutical Executive Daily: argenx Acquires Unnatural Products Inc.
Pharmaceutical Executive Daily: argenx Acquires Unnatural Products Inc.

argenx acquires Unnatural Products for up to $1.15 billion to expand its immunology capabilities, GiftHealth’s Chip Parkinson on how single-partner p…

1 week, 2 days ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro

Hims & Hers partners with Eli Lilly to sell Zepbound and Foundayo directly on its platform, Novo Nordisk terminates its research collaboration with K…

1 week, 5 days ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us